Tirzepatide Cost: What You May Pay and How Coverage Shifts It

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub — plain-language guidance on GLP-1 therapy, metabolic health, and the genetics behind individual response.

Tirzepatide is the active molecule behind more than one brand name, so pricing questions about it come with an extra wrinkle: the number depends on which branded form is prescribed and how it is covered. As of April 2026, the cost a person meets each month reflects insurance design, the indication on the prescription, savings-card eligibility, and pharmacy pricing far more than any headline figure. This page untangles those pieces one at a time.

What the molecule lists for

Tirzepatide-based products list at approximately $1,069 per month at U.S. list price as of April 2026, per Eli Lilly published pricing. That is the reference point before anything else applies. Rebates, formulary discounts, manufacturer cards, and pharmacy negotiation all sit between the list figure and your actual cost, which is why insured patients rarely pay the published number. Your plan, formulary, prior-authorization status, and prescribed indication set the real total.

Coverage and prior authorization

Commercial coverage of tirzepatide depends on the indication and each plan's formulary and prior-authorization criteria. Type 2 diabetes indications are commonly covered among commercial plans. Chronic weight-management coverage is more variable, is often gated behind BMI-based prior authorization, and is excluded by some plans entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for certain products. Your plan has the final word.

Lowering the monthly cost

Eli Lilly savings card

Eli Lilly publishes a savings-card program that can substantially cut monthly cost for eligible commercially-insured patients. Medicare, Medicaid, and TRICARE enrollees are typically excluded, and the card carries monthly and annual caps that change. Verify current terms on the manufacturer site before filling.

Pharmacy coupons

GoodRx, SingleCare, and comparable platforms post coupon prices that vary by pharmacy. Checking several pharmacies can surface a better cash price, though the discount depends on location and is not fixed.

The 2024–2025 shortage and compounding

While the FDA listed semaglutide and tirzepatide as in shortage, 503A compounding pharmacies could legally prepare compounded versions of these molecules. The agency declared the tirzepatide shortage resolved in early 2025 and the semaglutide shortage resolved in late 2024, tightening the compounding window without ending all legitimate activity. Compounded tirzepatide is not identical to an FDA-approved brand product and carries its own pricing.

Out-of-pocket, situation by situation

With a covered indication and a savings card, eligible patients may pay as little as $25 per month, subject to caps. Without indication coverage, cash cost sits near list price after any coupon. Uninsured patients approach list price; compounded routes through the PlexusDx Weight Management Protocols use separate published pricing, offered as Tirzepatide Injection and Tirzepatide Oral.

Genetics before the protocol

Ahead of any tirzepatide-pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants such as GIPR and FTO that influence appetite and energy balance. It is educational, trait-level information about your pathway biology — it does not predict response to any drug.

Related reading: Mounjaro 15mg, Mounjaro discounts, and Mounjaro price with insurance.

Frequently Asked Questions

How much does tirzepatide cost per month?

Tirzepatide products list around $1,069 per month at U.S. list price as of April 2026, per Eli Lilly published pricing. That is the pre-insurance figure. Coverage, savings cards, and pharmacy pricing can change the counter total substantially, so verify the current price with your pharmacy before filling.

Does insurance cover tirzepatide?

Coverage depends on the branded form, your plan's formulary, the FDA indication written, and prior-authorization criteria. Type 2 diabetes indications are commonly covered by commercial plans; weight-management coverage varies. Medicare does not cover weight-alone indications as of April 2026. Confirm how your specific plan treats tirzepatide before assuming any price.

Are there coupons for tirzepatide?

Eli Lilly publishes a savings-card program for eligible commercially-insured patients, and platforms like GoodRx list separate discount prices. Government-insurance patients are usually excluded from the manufacturer card, so confirm current eligibility and caps on the manufacturer site at fill time.

What does PlexusDx provide?

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed via licensed 503A compounding pharmacies with per-protocol pricing on each product page. Compounded products are not identical to brand medications and are not generics; this content is educational only.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.